1. Efficacy and safety of fosaprepitant in the prevention of nausea and vomiting following highly emetogenic chemotherapy in Chinese people: A randomized, double‐blind, phase III study. (10th April 2017) Authors: Yang, L.Q.; Sun, X.C.; Qin, S.K.; Cheng, Y.; Shi, J.H.; Chen, Z.D.; Wang, Q.M.; Zhang, H.L.; Hu, B.; Liu, B.; Zhang, Q.Y.; Wu, Q.; Wang, D.; Shu, Y.Q.; Dong, J.; Han, B.H.; Wang, K.M.; Dang, C.X.; Li, J.L.; Wang, H.B. Journal: European journal of cancer care Issue: Volume 26:Number 6(2017:Nov.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗